Association of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney Function

IMPORTANCE: Before 2016, safety concerns limited metformin use in patients with kidney disease; however, the effectiveness of metformin on clinical outcomes in patients with reduced kidney function remains unknown. OBJECTIVE: To compare major adverse cardiovascular events (MACE) among patients with...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:JAMA
Main Authors: Roumie, Christianne L., Chipman, Jonathan, Min, Jea Young, Hackstadt, Amber J., Hung, Adriana M., Greevy, Robert A., Grijalva, Carlos G., Elasy, Tom, Griffin, Marie R.
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2019
Teme:
Original Investigation
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6753652/
https://ncbi.nlm.nih.gov/pubmed/31536102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2019.13206
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki